@article {2197, title = {Why Preconception Treatment is Important? A Literature Reviews}, journal = {Pharmacognosy Journal}, volume = {15}, year = {2023}, month = {December 2023}, pages = {1262-1267}, type = {Review Article}, chapter = {1262}, abstract = {

Objective: Conceptional care is a concept that has been proposed to address maternal health problems and environmental risk factors during pregnancy to improve the health of both mother and fetus during pregnancy. This article provides an overview of several studies relating to preconception care that are useful for preparing for a healthy pregnancy and fetus. Methods: This narrative review uses several sources from the Elsevier database. Key search terms such as preconception, iron status, pregnancy and fetus were used in this review. Of the 50 studies identified, 20 were eligible for inclusion in this review. Results: Preconception care is getting an increased focus as an effective way to prevent complications during pregnancy, childbirth, and postpartum as well as preventing fetal abnormalities by estimating nutritional status in the preconception period. Preconception care is aimed at supporting the health of women before pregnancy, which is useful for improving the health of a pregnancy and preventing stunted fetal growth due to poor nutritional status in the mother. Low preconception iron status will have an impact on preconception gynecological morbidity, which will cause complications in pregnancy and cause low birth weight. Conclusion: Preconception care when given regularly will affect the health of a pregnancy and the baby when born. Preconception care teaches women of reproductive age to minimize potential health risks from an early age so that if they have a baby, the baby is born in better health. Considering that a healthy baby is very late if it is prepared during pregnancy but must be prepared from the preconception period, that is why preconception is so important.

}, keywords = {Fetus, Iron status, Preconception, Pregnancy}, doi = {10.5530/pj.2023.15.229}, author = {Darmin Dina and Nurhaedar Jafar and Veny Hadju and Hasnawati Amqam and Wahiduddin and Ridwan Amiruddin and Anwar Mallongi and Yulianah Sulaiman} } @article {1242, title = {Wound Healing Activity of an Ointment from Solanum tuberosum L. "Tumbay Yellow Potato" on Mus musculus Balb/c}, journal = {Pharmacognosy Journal}, volume = {12}, year = {2020}, month = {September 2020}, pages = {1268-1275}, type = {Original Article}, chapter = {1268}, abstract = {

Background: Solanum tuberosum L. is an Andean tuber that is mainly characterized by its antioxidant properties. Objective: To evaluate the healing activity of an S. tuberosum-based ointment on wounds induced in mice. Material and methods: Ethanolic extracts of peel and pulp of tubers of S. tuberosum "Tumbay yellow potato" were prepared, which were incorporated into 1\% and 2\% ointment formulations. Mus musculus Balb/c with induced wound were distributed in the following working groups: Group I (Negative Control), Group II (Positive Control: Neomycin, Polymyxin B and Bacitracin Ointment) and Groups III and IV (Ointment at 1 \% and 2\% of S. tuberosum extract, respectively), daily administration of topical treatments were carried out for 07 days. Wound closure was determined during the experimentation time, then euthanized with sodium pentobarbital 60 mg/kg b.w. (i.p.) to obtain skin samples for histopathological analysis. Results: Groups III and IV showed that better evidence of wound closure and scarring in the histopathological analysis, the greatest effect being in Group IV. Conclusions: S. tuberosum ointments show healing activity in induced wounds in mice, the most effective treatment being the 2\% ointment formulation.

}, keywords = {Histology, Skin, Solanum tuberosum, Wound Healing, Yellow potato}, doi = {10.5530/pj.2020.12.175}, author = {Galy P Rosas-Cruz and Carmen R Silva-Correa and Abhel A Calder{\'o}n-Pe{\~n}a and V{\'\i}ctor E Villarreal-La Torre and Cinthya L Aspajo-Villalaz and Jos{\'e} L. Cruzado-Razco and Jorge Del Rosario-Ch{\'a}varri and Juan C Rodr{\'\i}guez-Soto and Orlando E Pretel-Sevillano and William Antonio Sag{\'a}stegui-Guarniz and Anabel D Gonz{\'a}lez-Siccha} } @article {1094, title = {Wound Healing Activity of Ethanolic Extract of Selaginella Bryopteris on Rats}, journal = {Pharmacognosy Journal}, volume = {12}, year = {2020}, month = {March 2020}, pages = {335-341}, type = {Original Article}, chapter = {335}, abstract = {

The objective of the present study was to determine wound healing activity of ethanolic extract of Selaginella bryopteris on rats. The whole plant of S. bryopteris Linn. was collected from Andhra Pradesh, India and extraction was done using ethanol. GC-MS analysis was performed to determine active metabolites present in the extract followed by determination of total phenolic and flavonoid contents. In vivo wound healing activity of ethanolic extract was evaluated using excision wound model. The extract was applied topically on animals by preparing ointment in two concentrations (5\% and 10\%) where soframycin (10\%) was taken as positive control. Antioxidant activity of S. bryopteris extract was observed by measuring oxidative enzymatic levels i.e. Superoxide dismutase (SOD), Catalase (CAT), reduced Glutathione (GSH) and lipid peroxidation (LPO) in animal tissues. Histopathological studies of excised skin were carried out after the experimental period. The contraction rate of the wound was higher and dose-dependent in rats treated with 5\% and 10 \% ointment of extract in comparison to untreated control group. The drug treated groups showed recovery phase and the percentage of healing was more in 10\% at the end of experimental period. Results exhibited sufficient insights on the healing process with normal recovery stages and restored oxidative enzymatic levels. Histopathological findings provided additional positive results; the dermis with proliferating capillaries and skeletal muscle were replaced by cellular fibrous tissue and collagen fibers. Overall, the results showed that ethanolic extract of S.bryopteris was an interesting traditional agent that possess significant wound healing activity.

}, keywords = {Flavonoid content, Oxidative stress, Selaginellabryopteris, total phenolic content, Wound Excision Model}, doi = {10.5530/pj.2020.12.53}, author = {Shravan Kumar Paswan and Sajal Srivastava and Chandana Venkateswara Rao} } @article {976, title = {Wound Healing Activity of Ethanolic Extract of Selaginella Bryopteris on Rats (Retracted)}, journal = {Pharmacognosy Journal}, volume = {11}, year = {2019}, month = {September 2019}, pages = {984-990}, type = {Original Article}, chapter = {984}, abstract = {

This Article has been retracted due to Authors{\textquoteright} request.\ 

}, doi = {10.5530/pj.2019.11.155}, author = {Shravan Kumar Paswan and Sajal Srivastava and Chandana Venkateswara Rao} } @article {739, title = {Withaferin A attenuates Alcohol Abstinence Signs in Rats}, journal = {Pharmacognosy Journal}, volume = {10}, year = {2018}, month = {August 2018}, pages = {1190-1195}, type = {Original Article}, chapter = {1190}, abstract = {

Background: Withania somnifera (WS) have been reported to inhibit acquisition and expression conditioned place preference, self-administration and withdrawal anxiety of psychostimulants. In the present work, we have assessed the effect of withaferin A on somatic and affective symptoms of ethanol withdrawal syndrome in rats. Methods: Animals had given free access to ethanol uninterrupted for 21 days through liquid diet. Withaferin A (5, 10 and 20 mg/kg) was injected (ip) either during the development of ethanol dependence phase (days 15 \– 21 or 30 min before ethanol withdrawal assessment. Withdrawal signs characterized by changes in somatic signs were measured in the open field followed by evaluation of anxiety parameters, locomotion, and depressive behavior. Results: Withaferin A treatment 30 min before 24 h postethanol withdrawal assessment did not alter the scores of somatic behavioral signs in ethanol abstinence animals. However, withaferin A (10 and 20 mg/kg, ip) from day 15-21 prevented the ethanol withdrawal-induced elevated scores of somatic behaviors, hyperlocomotion, depressive behavior, and anxiety. Withaferin A treatment did not influence the blood ethanol levels in dependent and withdrawn animals. However, withaferin A administration attenuated the elevated plasma corticosterone and ACTH levels in ethanol-withdrawn rats, suggesting withaferin A induced anti-stress effect and stabilization of HPA axis activity could have facilitated the inhibitory effect of withaferin A on ethanol withdrawal syndrome. Conclusion: The finding supports further investigation of withaferin A and other bioactive components of WS in alcohol addiction.

}, keywords = {Anxiety, Corticosterone, Ethanol withdrawal, HPA axis, Withaferin A.}, doi = {xx10.5530/pj.2018.6.204}, author = {Nandkishor Ramdas Kotagale and Ankit Kedia and Rupali Gite and Shubham Nilkanth Rahmatkar and Dinesh Yugraj Gawande and Milind Janraoji Umekar and Brijesh Gulabrao Taksande} }